Abstract:Background: Prostate cancer (PC) ranks as the fifth deadliest tumor in the world and has been regarded as a serious threat for the life and health of middle-aged and elderly men. Some studies have shown that LINC00861 regulated the anti-tumor immune response, and may have a certain impact on tumor immunotherapy. Therefore, to explore the related role of LINC00861 in PC, we detected the expression of LINC00861 in PC, and regulated the expression of LINC00861 after confirming its expression. This study aimed to explore the potential of LINC00861 in promoting the immunity of cytotoxic T cells and influencing the biological behavior of PC cells and tumor growth by regulating programmed cell death 1 ligand 1 (PD-L1).Methods: Expression of LINC00861 and PD-L1 was detected in 10 cases of PC and adjacent tissues. Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) analysis was performed to assess the expression level of LINC00861 in cancer cells. Cell lines with differential expression were selected for interference and overexpression of LINC00861, followed by grouping. The vitality of PC cells was observed, and measurements were taken for cell proliferation, migration, invasion, PD-L1, B-cell lymphoma-2 (Bcl-2), Bcl-2-associated X protein (Bax), and expression of inflammatory factors such as Interleukin (IL)-6, IL-8, and tumor necrosis factor (TNF)-alpha in the cells. To establish the subcutaneous PC tumor model, PC cells from each group were subcutaneously implanted in the right flank of BALB/c mice using 100 mu L of phosphate-buffered saline (PBS). Mouse tumor tissues were collected to observe tumor size, assess tumor-infiltrating lymphocytes, and evaluate the infiltration of cytotoxic T cells (CD3(+) and CD8(+)).Results: In PC tissues and cells, PC-3 cells were selected for subsequent experiments through cell screening. Successful transfection of LINC00861 inhibition and overexpression vectors was achieved in PC cells. Inhibiting the expression of LINC00861 upregulated the expression of PD-L1, enhanced cell growth vitality, proliferation, migration, invasion, and cytokine production capabilities, and reduced apoptosis. Overexpression reversed these effects. In in vivo experiments, inhibiting LINC00861 expression resulted in rapid tumor growth, accompanied by increased tumor volume and dense tumor tissue cells. Overexpression of LINC00861 produced the opposite results for these effects. The findings also indicated that inhibiting LINC00861 led to a significant increase in PD-L1 expression in tumor tissues and a significant decrease in CD3(+) T and CD8(+) T levels (p < 0.05). When LINC00861 was overexpressed, PD-L1 levels were reduced, while CD3(+) T and CD8(+) T levels were improved.Conclusions: LINC00861 is down-regulated in PC tissues. The inhibition of LINC00861 increases the expression of PD-L1, inhibits cytotoxic T cells immunity, and enhances the growth of PC cells and tumor growth and metastasis. Overexpression inhibits the development of PC.

Effection of Prostate Cancer Antigen 3(PCA3) on Proliferation of LNCaP Cells

CRABP2 Promotes Cell Migration and Invasion by Activating PI3K/AKT and MAPK Signalling Pathways Via Upregulating LAMB3 in Prostate Cancer

Synergistic effect of Nkx3.1 and p27 Proteins in Human prostate cancer cells

Expression of lncRNA PCGEM1 and AR co-localization in prostate cancer and tis signiifcance

Effect of prostate-specific membrane antigen on phospho-ERK, growth and migration of prostate cancer LNCaP cells

Effects of PSA expression inhibition by RNA interference on the cancer cells proliferation and invasion in human prostate cancer 22RV1 cells

Diagnostic Performance of PCA3 and Hk2 in Combination with Serum PSA for Prostate Cancer.

lncRNA PCA3 plays a key role in colon cancer occurrence and development

Effect of the Circcdr1as/mir-641/Xiap Regulatory Axis on the Proliferation and Invasion of the Prostate Cancer PC-3 Cell Line

Androgen-responsive lncRNA LINC00304 promotes cell cycle and proliferation via regulating CCNA1.

Prostate Specific Membrane Antigen Knockdown Impairs the Tumorigenicity of LNCaP Prostate Cancer Cells by Inhibiting the Phosphatidylinositol 3-Kinase/akt Signaling Pathway.

Retracted Article: Long Noncoding RNA PCA3 Regulates Glycolysis, Viability and Apoptosis by Mediating the Mir-1/Cdk4 Axis in Prostate Cancer

Expression and clinical significance of long non-coding RNA PCAT4 in prostate cancer

LncRNA MCM3AP-AS1 Promotes Cell Proliferation and Invasion Through Regulating Mir-543-3p/slc39a10/pten Axis in Prostate Cancer.

Construction of eukaryotic expression vector and package of lentivirus vector encoding prostate cancer antigen 3

Urinary PCA3 as a new predictive biomarker in prostate cancer aggression

LINC00861 Promotes Immune Response in the Tumor Microenvironment and Inhibits Prostate Cancer Tumor Growth by Regulating PD-L1

The Prostate Cancer-Up-regulated Long Noncoding RNA PlncRNA-1 Modulates Apoptosis and Proliferation Through Reciprocal Regulation of Androgen Receptor.

[Expression of long noncoding RNA LINC01358 in prostate cancer and its effect on the proliferation and migration of prostate cancer cells].

[Long Noncoding RNA Linc00662 Promotes the Tumorigenesis of Prostate Cancer Cells].

Function of PCA3 in Prostate Tissue and Clinical Research Progress on Developing a PCA3 Score.